TITLE

Importance of Placebo Effect in Cough Clinical Trials

AUTHOR(S)
Eccles, Ron
PUB. DATE
February 2010
SOURCE
Lung;Feb2010 Supplement 1, Vol. 188, p53
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cough is a unique symptom because, unlike sneeze and other symptoms, it can be under voluntary control and this complicates clinical trials on cough medicines. All over-the-counter cough medicines (OTC) are very effective treatments because of their placebo effect. The placebo effect is enhanced by expectancy related to advertising, brand, packaging, and formulation. This placebo effect creates a problem for the conduct of clinical trials on OTC cough medicines that attempt to demonstrate the efficacy of a pharmacological agent above that of any placebo effect. Up to 85% of the efficacy of some cough medicines can be attributed to a placebo effect. The placebo effect apparent in clinical trials consists of several components: natural recovery, regression of cough response toward mean, demulcent effect, effect of sweetness, voluntary control, and effects related to expectancy and meaning of the treatment. The placebo effect has been studied most in the pain model, and placebo analgesia is reported to depend on the activation of endogenous opioid systems in the brain; this model may be applicable to cough. A balanced placebo design may help to control for the placebo effect, but this trial design may not be acceptable due to deception of patients. The placebo effect in clinical trials may be controlled by use of a crossover design, where feasible, and the changes in the magnitude of the placebo effect in this study design are discussed.
ACCESSION #
47853747

 

Related Articles

  • The Powerful Placebo Effect in Cough: Relevance to Treatment and Clinical Trials. Eccles, Ron // Lung;Feb2020, Vol. 198 Issue 1, p13 

    Interest in the placebo effect of medicines has developed from the use of placebo treatments as controls in clinical trials into a whole new area of research around how placebos fit into a psychosocial model of therapeutics. The large placebo effect associated with cough medicines is both a...

  • Review: intravenous metocloprarnide is better than placebo For reducing pain in acute migraine in the emergency department. Loder, Elizabeth W. // Evidence Based Medicine;Jun2005, Vol. 10 Issue 3, p83 

    The article presents information on a study published in the 2004 issue of the British Medical Journal, which analyzed if meloclopramide is more effective than a control intervention for reducing symptoms in patients with acute migraine. In studies comparing drug combinations, more patients...

  • PII-67. Schachtel, B. P.; Sanner, K. M.; Schachtel, E. P. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP53 

    Background: Since Beecher and Lasagna described placebo (PBO) response rates in trials on various therapies,1. clinical investigators have encountered mean PBO responses for symptoms that are variable and high, often obscuring the differentiation of drugs from PBO. IRRs may be a better method of...

  • Is there a place for placebo controlled trials of antiepileptic drugs? Shorvon, S.D.; Espir, M.L.E.; Steiner, T.J.; Dellaportas, C.I.; Rose, F. Clifford // British Medical Journal (Clinical Research Edition);11/9/1985, Vol. 291 Issue 6505, p1328 

    Examines the possibility of a placebo controlled trials on antiepileptic drugs in Great Britain. Uncertainty on the role of anticonvulsant drugs on epileptics; Impact of epileptic seizures on the psychology and social behavior of epileptics; Natural history of epilepsy.

  • Withholding Proven Treatment in Clinical Research. Huston, Patricia; Peterson, Robert // New England Journal of Medicine;9/20/2001, Vol. 345 Issue 12, p912 

    Editorial. Discusses the ethics of placebo-controlled clinical trials. Role of the Declaration of Helsinki; Need for scientific and ethical justification of the use of placebos.

  • Is the Placebo Powerless? Hróbjartsson, Asbjørn; Gøtzsche, Peter C. // New England Journal of Medicine;05/24/2001, Vol. 344 Issue 21, p1594 

    Background: Placebo treatments have been reported to help patients with many diseases, but the quality of the evidence supporting this finding has not been rigorously evaluated. Methods: We conducted a systematic review of clinical trials in which patients were randomly assigned to either...

  • An Evaluation of Arbaprostil at Multiple Doses for the Treatment of Acute Duodenal Ulcer: A Randomized Double Blind Placebo-Controlled International Trial. Euler, A. R.; Krawiec, J.; Odes, H.; Gilat, T.; Garcia, L.; Rachmilewitz, D.; Gabryelewicz, A.; Gibinski, K.; Bass, D.; Barbara, L.; Porro, G. Bianchi; Lazzaroni, M.; Kirchmayer, S.; Nago-Nago, A.; Popiela, T.; Kulig, J.; Roca, M.; Hagenmuller, F.; Bergemann, W.; Schryver, M. // American Journal of Gastroenterology;Feb1990, Vol. 85 Issue 2, p145 

    Six hundred and thirty patients were enrolled in a randomized double-blind placebo-controlled trial evaluating two arbaprostil dosages (25 µg and 50 µg) qid for 4 wk for the treatment of acute duodonal ulcers. The healing rates in the placebo, 25-µg, and 50-µg treatment groups were...

  • Growth hormone reduced HIV-related visceral fat.  // Hem/Onc Today;11/10/2008, Vol. 9 Issue 20, p40 

    The article discusses findings of a randomized, double-blind, placebo-controlled trial that was conducted by researchers from Massachusetts General Hospital in Boston, which examined the efficacy of low-dose growth hormone on body composition, glucose and cardiovascular factors as observed among...

  • Gabapentin - the 'Holy Grail' for chronic cough suffers?  // PharmacoEconomics & Outcomes News;9/15/2012, Issue 662, p10 

    The article discusses the results of a placebo-controlled study which shows that gabapentin treatment resulted in improvements in the cough-specific quality of life (QOL) of patients with refractory chronic cough. It references the research "Gabapentin for refractory chronic cough: A randomised,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics